Results 211 to 220 of about 240,839 (324)
Diagnostic Cytopathology, Volume 53, Issue 6, Page E102-E107, June 2025.ABSTRACT Lung adenocarcinoma is a common malignancy that can metastasize. The lung is also a common site for metastasis from other sites. Prompt and accurate diagnosis is critical for patient management. The diagnosis of lung adenocarcinoma can be occasionally challenging due to overlapping clinical and pathological features with adenocarcinomas from ...
Robert Pei +2 more
wiley +1 more source
Dual CRISPR-Cas3 system for inducing multi-exon skipping in DMD patient-derived iPSCs. [PDF]
Stem Cell Reports, 2023 Kita Y +10 more
europepmc +1 more source
Atypical 5′ Splice Sites Cause CFTR Exon 9 To Be Vulnerable to Skipping [PDF]
, 2002 Timothy Hefferon +3 more
openalex +1 more source
Fexofenadine Overcomes Osimertinib Resistance by Inhibiting c‐Met in Non‐Small Cell Lung Cancer
MedComm – Oncology, Volume 4, Issue 2, June 2025.Fexofenadine was identified as a new Met inhibitory drug by a computational drug repurposing tool called “DRAR‐CPI” via chemical‐protein interactome analysis of known Met inhibitors. It was shown to overcome osimertinib resistance in non‐small cell lung cancer by inhibiting Met in vitro and in vivo.
Kenneth K. W. To +2 more
wiley +1 more source
Identification of cryptic splice site, exon skipping, and novel point mutations in type I CD36 deficiency [PDF]
, 2002 Haruo Hanawa
openalex +1 more source
The Plant Genome, Volume 18, Issue 2, June 2025.Abstract The different steps of alternative splicing (AS) in plants and its regulatory mechanisms have already been studied extensively. Its broader impact on cell identity, plant immunity‐related genes, and their study as a whole remains to be investigated.
Teura Barff +5 more
wiley +1 more source
Ensemble-Learning and Feature Selection Techniques for Enhanced Antisense Oligonucleotide Efficacy Prediction in Exon Skipping. [PDF]
Pharmaceutics, 2023 Zhu A +6 more
europepmc +1 more source